DIVISLAB.NS vs PODD — which is stronger right now?
Same dated snapshot (2026-09-01): DIVISLAB.NS quality —/100 vs PODD 100/100; engine LONG vs WAIT. The comparison below is computed, dated, and auditable — not an opinion.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| DIVISLAB.NS (Divi's Laboratories) | PODD (Insulet) | |
| Market / sector | in · Pharma | us · Healthcare |
| Price | ₹9,121 | $143.41 |
| Quality score | —/100 | 100/100 |
| Engine signal | LONG · 218 bars · uPnL +40.9% | WAIT · 28 bars · uPnL +0.0% |
| Total return | +25.3% | -30.3% |
Thesis-break template (Pharma)
flagship drug losing exclusivity; pivotal trial failure; pricing-policy shifts; payer consolidation
Cite this page
Balance Labs Research Desk (2026-09-01). "DIVISLAB.NS vs PODD — which is stronger right now?." balancelabs.app · https://balancelabs.app/stocks/compare/divislab.ns-vs-podd · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← compare hub · snapshot 2026-09-01 · not investment advice